Internal Reference Number: FOI_7995
Date Request Received: 12/06/2024 00:00:00
Date Request Replied To: 27/06/2024 00:00:00
This response was sent via: By Email
Request Summary: Cancer Treatment using Specified Products
Request Category: Private Individuals
| Question Number 1: 1) In the past 6 months, what was the number of patients treated with a combination of Dabrafenib + Trametinib for the following conditions: A) Metastatic Melanoma B) Adjuvant Melanoma C) BRAF mutated Lung Cancer | |
| Answer To Question 1: A) 0 patients B) 0 patients C) <5 patients | |
| Question Number 2: 2) In the past 6 months, what was the number of patients treated with a combination of Encorafenib (Braftovi) + Binimetnib (Mektovi) for the following conditions: A) Metastatic Melanoma B) Colorectal Cancer | |
| Answer To Question 2: A) 0 patients B) 0 patients | |
| To return to the list of all the FOI requests please click here |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of ¾¨Ó㴫ý Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
